Applied DNA Stock News

Applied DNA Sciences (APDN) is a tiny microcap healthcare stock with a 37-year history in business -- but no profits, and almost no (less than $5 million annual) revenues. Despite this somewhat mixed

It is a pleasure to report that the Applied DNA Sciences, Inc. (NASDAQ:APDN) is up 337% in the last quarter. But will...

Applied DNA Sciences, Inc. (NASDAQ:APDN) Q2 2020 Earnings Conference Call May 14, 2020 04:30 PM ET Company Participants Judy Murrah - Chief Information Officer

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 14) Allogene Therapeutics Inc (...

Applied DNA Sciences Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company") a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic ac

U.S. stocks traded down Thursday, but off earlier lows after data showed nearly another 3 million Americans lost jobs last week, down slightly from the prior...

U.S. stock-index futures traded sharply lower Thursday after data showed nearly another 3 million Americans lost jobs last week, down slightly from the prior...

Applied DNA Sciences' coronavirus test kit is now cleared under the FDA's emergency-use authorization.

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs May 13.) * AstraZeneca plc (NYSE: AZN) * AtriCure Inc. (NASD

Shares of Applied DNA Sciences Inc. [: apdn] soared 66.2% in premarket trading on Thursday after the company announced emergency use authorization from the...

Shares of Applied DNA Sciences Inc. [: apdn] soared 66.2% in premarket trading on Thursday after the company announced emergency use authorization from the Food and Drug Administration for its COVID-1

Applied DNA Sciences Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company," "our") announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the

Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company,” “our”) announced today that the U.S. Food and Drug Administration (FDA) has

The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...

Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today it plans to release financial results for its fiscal 2020 second quarter ended March 31, 2020 after market close on Thursday, May 14, 2020. I